[Asia Economy Reporter Minwoo Lee] ShillaJen announced on the 25th that it has decided to transfer 1 million shares of NeoImmuneTech for 10.1 billion KRW to secure cash liquidity. The planned disposal period is from the 26th to November 25, 2022.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing